Atara Biotherapeutics (ATRA) Change in Taxes (2013 - 2014)
Atara Biotherapeutics' (ATRA) quarterly Change in Taxes came in at -$62000.0 in Q4 2014, down 145.26% YoY from $137000.0 in Q4 2013, and up 32.61% on a QoQ basis from -$92000.0 in Q1 2014.
Atara Biotherapeutics (ATRA) Change in Taxes (2013 - 2014) Analysis & Trends
Atara Biotherapeutics (ATRA) has 2 years of Change in Taxes data on file, last reported at -$62000.0 in Q4 2014.
- Quarterly Change in Taxes fell 145.26% year-over-year to -$62000.0 in Q4 2014, while the trailing twelve-month figure through Dec 2014 was -$154000.0 (changed N/A YoY) and the FY2014 annual result came in at -$154000.0, down 204.05% from the prior year.
- Change in Taxes improved to -$62000.0 in Q4 2014, from -$92000.0 in the prior quarter.
- In the past five years, Change in Taxes ranged from a high of $137000.0 in Q4 2013 to a low of -$92000.0 in Q1 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 90.33 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Atara Biotherapeutics | 141.08 Mn | 124.53 Mn | 439,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2014 | -62,000.00 |
| Dec 31, 2014 | -62,000.00 |
| Mar 31, 2014 | -92,000.00 |
| Mar 31, 2014 | -92,000.00 |
| Dec 31, 2013 | 137,000.00 |
| Dec 31, 2013 | 137,000.00 |